“Vitamin A” on a supplement label can mean two different things — preformed vitamin A (retinol or retinyl palmitate/acetate) or beta-carotene, a plant pigment the body converts to vitamin A as needed. Brands abroad ask for a Japan-made vitamin A product without always knowing that the two forms carry different risks, different regulatory wording, and — for beta-carotene at high doses in smokers — a genuinely bad safety history in clinical trials.
This guide separates what Japan’s nutrient-function labelling system permits for vitamin A, what the large randomised trials of beta-carotene actually found, and what that means for formulating and marketing a Japan-made product honestly.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a vitamin A or beta-carotene product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
In large randomised trials, high-dose beta-carotene supplements given to smokers increased lung cancer incidence rather than preventing it — a result that reversed what researchers had expected.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| ATBC Cancer Prevention Study, New England Journal of Medicine 1994 (PMID 8127329) | Randomised, double-blind, placebo-controlled trial; 29,133 male smokers aged 50–69 in Finland; 50 mg/day alpha-tocopherol and/or 20 mg/day beta-carotene for 5–8 years | Beta-carotene group had 18% higher lung cancer incidence (95% CI 3–36%) and 8% higher total mortality (95% CI 1–16%) than placebo; alpha-tocopherol showed no effect on lung cancer |
| CARET, New England Journal of Medicine 1996 (PMID 8602180) | Randomised, double-blind, placebo-controlled trial; 18,314 smokers, former smokers and asbestos-exposed workers; 30 mg/day beta-carotene plus 25,000 IU/day retinyl palmitate; stopped 21 months early | Lung cancer incidence relative risk 1.28 (95% CI 1.04–1.57); lung cancer mortality relative risk 1.46 (95% CI 1.07–2.00); all-cause mortality relative risk 1.17 (95% CI 1.03–1.33) |
| Cochrane systematic review, 2012 (PMID 22419320) | 78 randomised trials, 296,707 participants, antioxidant supplements (beta-carotene, vitamin A, vitamin C, vitamin E, selenium) versus placebo | In trials with low risk of bias, beta-carotene supplementation increased mortality (relative risk 1.05, 95% CI 1.01–1.09); the review found “no evidence to support antioxidant supplements for primary or secondary prevention” |
Both ATBC and CARET tested smokers or asbestos-exposed workers specifically, at doses well above typical dietary intake (20–30 mg/day beta-carotene, plus high-dose retinol in CARET), and both were stopped or reported early because of the harm signal rather than continued for a planned benefit. The Cochrane review, covering the general population across many trials, still found a small but statistically significant increase in mortality with beta-carotene in its most rigorous subgroup. None of these trials tested beta-carotene from food or at typical multivitamin doses in non-smokers, and none of this evidence applies to preformed vitamin A at nutrient-function-label doses.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Japan’s Foods with Nutrient Function Claims (栄養機能食品) system lets a vitamin A product carry one or both of two fixed sentences once the daily intake amount falls between 231 μg and 600 μg, with a mandatory caution aimed specifically at women who are or may become pregnant.
Under the Consumer Affairs Agency’s Food Labeling Standards, vitamin A qualifies for this labelling route without premarket notification once the stated daily amount sits inside that range. The two permitted function statements (our translation) are:
- “Vitamin A is a nutrient that helps maintain vision at night.”
- “Vitamin A is a nutrient that helps maintain the health of skin and mucous membranes.”
The mandatory caution wording includes the standard “does not cure disease” sentence, plus a caution that applies specifically to this nutrient (our translation): “Women who are within three months of pregnancy, or who wish to become pregnant, should take care not to consume excessive amounts.”
This pregnancy-specific wording reflects a real and independently documented risk: preformed vitamin A at high doses is teratogenic, which is why regulators in multiple countries set a distinct, lower tolerable upper intake level consideration for women of childbearing age. Japan’s system does not extend a nutrient-function claim to beta-carotene as a separate labelling category in the same way.
Two points for a brand abroad:
- The Japanese wording covers ordinary nutrient adequacy — night vision and skin and mucous membrane health — not disease prevention. It says nothing about the beta-carotene trials above, which used doses and populations entirely outside this framework.
- The pregnancy caution is not boilerplate. It exists because preformed vitamin A, unlike beta-carotene from food, is teratogenic at high intakes, and it must appear in full wherever the function claim appears.
💬 Need help separating preformed vitamin A from beta-carotene in your formula and labelling? We prepare the comparison with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Keep vitamin A and beta-carotene claims tied to nutrient adequacy, and never imply that beta-carotene supplementation prevents cancer.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains vitamin A” with the amount per serving, inside Japan’s notified range if using the Japanese wording | ”Boosts immunity” or any cancer-prevention or anti-cancer claim |
| ”A source of beta-carotene, a provitamin A carotenoid” | Implying beta-carotene supplements are protective for smokers, or safe at high dose for anyone who smokes |
| Naming the pregnancy caution plainly on preformed vitamin A products | Omitting or softening the pregnancy caution to make the label look simpler |
How vitamin A and beta-carotene are formulated
Preformed vitamin A (retinyl palmitate or acetate) and beta-carotene behave differently in formulation as well as in the body, so the choice between them is a specification decision, not just a marketing one.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Softgel (oil-based) | Vitamin A and beta-carotene are fat-soluble; softgels suit an oil carrier | Oxidation sensitivity; needs proper packaging |
| Tablet or capsule with dry/beadlet form | Easier to combine with other vitamins and minerals | Beadlet stability depends on the supplier’s coating |
| Multivitamin blend | Common route for general nutrient-adequacy products | Total vitamin A across all sources in the formula must stay inside the intended range |
Decisions that shape the specification:
- Preformed vitamin A versus beta-carotene. These are different ingredients with different safety profiles at high dose; a formula should specify which one, and in what proportion if both are used.
- Amount per serving. For a Japanese Foods with Nutrient Function Claims product, the daily vitamin A amount must sit between 231 μg and 600 μg. Products combining vitamin A from multiple ingredients (fish oil, liver-derived materials, fortified components) need the total counted, not just the added vitamin A.
- Population. Any formula intended for women who may be pregnant needs the mandatory caution, and a brand selling in multiple markets should check whether its other markets set a lower ceiling for vitamin A during pregnancy.
- Oxidation and stability. Both forms are sensitive to light, heat and oxygen; packaging and any antioxidant companions (such as vitamin E) affect shelf life.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Vitamin A and beta-carotene are both established food ingredients in Japan. The formulation risk sits mainly in dose — staying inside Japan’s nutrient-function range if using that wording, and being honest about what the beta-carotene trials in smokers actually showed. See the Japan-made supplement OEM page, and compare with our vitamin D and vitamin E guides for how the same nutrient-function system applies to other fat-soluble vitamins.
Before you ask for a quotation
A factory can quote accurately once the vitamin A form, the amount, and the target population are fixed.
- Preformed vitamin A, beta-carotene, or both, and the amount per serving
- Whether you intend to use Japan’s Foods with Nutrient Function Claims wording, and if so, confirmation the amount falls inside 231–600 μg
- Dosage form — softgel, tablet or capsule
- Companion ingredients and their amounts
- Whether the product is marketed to, or excludes, women who are or may become pregnant
- Countries you will sell in, and vitamin A’s status and upper-limit guidance there
💬 Ready to design a Japan-made vitamin A or beta-carotene product? Send us the concept — amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Is beta-carotene safer than preformed vitamin A because it is “natural”?
Not automatically. Large randomised trials found that high-dose beta-carotene supplements increased lung cancer incidence and mortality in smokers, a result researchers did not expect. Neither form should be assumed to have a purely protective effect at supplement doses.
2. Does the beta-carotene research mean no one should take it?
The trials tested smokers and asbestos-exposed workers at doses well above typical intake. They do not describe beta-carotene from food, and do not test typical multivitamin doses in non-smokers. The honest position is that high-dose beta-carotene supplementation in smokers is specifically discouraged by this evidence.
3. What can a Japan-made vitamin A product say on its Japanese label?
If the daily amount is between 231 μg and 600 μg, it can carry fixed wording about night vision and about skin and mucous membrane health, plus the mandatory caution — including the specific caution for women within three months of pregnancy or planning pregnancy.
4. Why does Japan single out pregnancy for vitamin A but not for beta-carotene?
Preformed vitamin A is teratogenic at high intakes, which is a documented risk distinct from beta-carotene, since the body’s conversion of beta-carotene to vitamin A is self-limiting. That is the basis for the pregnancy-specific caution on preformed vitamin A labels.
5. Can beta-carotene and preformed vitamin A be combined in one product?
Yes, and Japanese multivitamins often do. The formulation question is what total vitamin A activity results, and whether the product’s marketing and any pregnancy caution reflect that total honestly.
Sources: “The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers”, New England Journal of Medicine 1994;330(15):1029-1035 (PMID 8127329); “Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease”, New England Journal of Medicine 1996;334(18):1150-1155 (PMID 8602180); “Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases”, Cochrane Database of Systematic Reviews 2012 (PMID 22419320); hfnet.nibn.go.jp (National Institutes of Biomedical Innovation, Health and Nutrition) for vitamin A Foods with Nutrient Function Claims wording, caution statements and lower/upper limits. Checked on 25 September 2026.